<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[genentech inc. and license agreement Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/genentech+inc.+and+license+agreement.html?i=11]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to genentech inc. and license agreement]]></description>
	<s:counts start="0" returned="5" found="5" />
	<language>en-us</language>
	<item>
		<title><![CDATA[BioWa Announces Expansion of License Agreement with Genentech for BioWa's POTELLIGENT(R) Technology.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200803/ai_n25296412]]></link>
		<description><![CDATA[PRINCETON, New Jersey, March 3 /PRNewswire/ --     PRINCETON, New Jersey, March 3 /PRNewswire/ --   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Mar 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Amgen and Genentech Sign License Agreements For Antibody Patents]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_Jan_26/ai_n26736646]]></link>
		<description><![CDATA[THOUSAND OAKS, Calif. & SOUTH SAN FRANCISCO, Calif. -- Amgen (NASDAQ:AMGN) and Genentech Inc. (NYSE:DNA) today announced that they have entered into license agreements granting licenses to each other under multiple patents relating to the manufacture and use of antibodies and related technology. These agreements include a grant by Genentech...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 26 Jan 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">AMGN,DNA</category>
	</item>
	<item>
		<title><![CDATA[Trillium and Genentech Enter Into Global License Agreement.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200412/ai_n24118632]]></link>
		<description><![CDATA[TORONTO, December 14 /PRNewswire/ --     Trillium Therapeutics Inc.  TTI, a Canadian biopharmaceutical company, announced today that it has  entered into an agreement with Genentech, Inc. (NYSE: DNA), granting the  latter exclusive worldwide rights to  TORONTO, December 14 /PRNewswire/ --   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 14 Dec 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Agensys Signs Collaboration and License Agreement with Genentech]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_22/ai_n6118076]]></link>
		<description><![CDATA[SANTA MONICA, Calif. -- Agensys, Inc., a cancer biotechnology company, today announced an agreement with Genentech Inc. (NYSE:DNA) for the research, development and commercialization of therapeutic and diagnostic products to two of Agensys' proprietary cancer targets. The agreement provides Genentech with exclusive worldwide licenses under Agensys' patent rights for the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Jul 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/collaboration.html"><![CDATA[collaboration]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Genentech and Immunex Announce Patent License Agreement for Immunoadhesin Technology for ENBREL]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_June_8/ai_54817327]]></link>
		<description><![CDATA[SOUTH SAN FRANCISCO, Calif. and SEATTLE--BW HealthWire--June 8, 1999--]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Jun 1999 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/license+agreement.html"><![CDATA[license agreement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
</channel>
</rss>
